MX9300948A - Un antagonista novedoso del receptor 5ht3 - Google Patents

Un antagonista novedoso del receptor 5ht3

Info

Publication number
MX9300948A
MX9300948A MX9300948A MX9300948A MX9300948A MX 9300948 A MX9300948 A MX 9300948A MX 9300948 A MX9300948 A MX 9300948A MX 9300948 A MX9300948 A MX 9300948A MX 9300948 A MX9300948 A MX 9300948A
Authority
MX
Mexico
Prior art keywords
treatment
receiver
antagonist
novel
novel antagonist
Prior art date
Application number
MX9300948A
Other languages
English (en)
Spanish (es)
Inventor
Maurice W Gittos
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of MX9300948A publication Critical patent/MX9300948A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MX9300948A 1992-02-24 1993-02-22 Un antagonista novedoso del receptor 5ht3 MX9300948A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92400474 1992-02-24

Publications (1)

Publication Number Publication Date
MX9300948A true MX9300948A (es) 1993-08-01

Family

ID=8211614

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9300948A MX9300948A (es) 1992-02-24 1993-02-22 Un antagonista novedoso del receptor 5ht3

Country Status (14)

Country Link
EP (1) EP0628043A1 (enrdf_load_html_response)
JP (1) JPH07504192A (enrdf_load_html_response)
KR (1) KR100287933B1 (enrdf_load_html_response)
AU (1) AU675060B2 (enrdf_load_html_response)
CA (1) CA2130563C (enrdf_load_html_response)
FI (1) FI105917B (enrdf_load_html_response)
HU (1) HU216831B (enrdf_load_html_response)
IL (1) IL104821A (enrdf_load_html_response)
MX (1) MX9300948A (enrdf_load_html_response)
NO (1) NO943101L (enrdf_load_html_response)
NZ (1) NZ249346A (enrdf_load_html_response)
TW (1) TW226374B (enrdf_load_html_response)
WO (1) WO1993017019A1 (enrdf_load_html_response)
ZA (1) ZA931146B (enrdf_load_html_response)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2672500A (en) 1999-02-18 2000-09-04 Novartis Ag Systemic use of 5-ht3 receptor antagonists against rheumatic inflammatory processes
US8518962B2 (en) 2005-03-07 2013-08-27 The University Of Chicago Use of opioid antagonists
JP5241484B2 (ja) 2005-03-07 2013-07-17 ザ ユニヴァーシティー オヴ シカゴ 内皮細胞増殖及び内皮細胞遊走を減弱するためのオピオイドアンタゴニストの使用
US8524731B2 (en) 2005-03-07 2013-09-03 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US9662325B2 (en) 2005-03-07 2017-05-30 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2080727T3 (es) * 1988-02-23 1996-02-16 Merrell Pharma Inc Uso de quinolizina y derivados de quinolizinona en la fabricacion de medicamentos.
EP0517984A1 (en) * 1991-06-11 1992-12-16 Merrell Dow Pharmaceuticals Inc. Derivatives of amide analogs of certain methano bridged quinolizines

Also Published As

Publication number Publication date
TW226374B (enrdf_load_html_response) 1994-07-11
NO943101D0 (no) 1994-08-23
KR950700297A (ko) 1995-01-16
FI943872L (fi) 1994-08-23
ZA931146B (en) 1993-09-14
HUT68249A (en) 1995-06-28
CA2130563A1 (en) 1993-09-02
JPH07504192A (ja) 1995-05-11
EP0628043A1 (en) 1994-12-14
CA2130563C (en) 1997-11-11
AU3603493A (en) 1993-09-13
NO943101L (no) 1994-08-23
AU675060B2 (en) 1997-01-23
FI943872A0 (fi) 1994-08-23
NZ249346A (en) 1995-10-26
HU9402436D0 (en) 1994-10-28
IL104821A (en) 1997-01-10
FI105917B (fi) 2000-10-31
IL104821A0 (en) 1993-06-10
HU216831B (hu) 1999-09-28
WO1993017019A1 (en) 1993-09-02
KR100287933B1 (ko) 2001-05-02

Similar Documents

Publication Publication Date Title
EA199800340A1 (ru) Производные пиримидина как антагонисты 5нт2с
UA27776C2 (uk) Похідні хінуклідину та їх фармацевтично прийнятні солі, що є антагоністами речовини р у ссавців, фармацевтична композиція, що має антагоністичну дію на речовину р у ссавців
EA199900045A1 (ru) Производные спиропиперидина и их использование в качестве терапевтических агентов
BR9609013A (pt) Análogo de nucleosìdeos, e, composto.
BG101806A (bg) Индолови производни като антагонисти на 5-нт рецептори
MX9300977A (es) Compuetos heterobiciclicos.
ECSP941135A (es) Antagonistas triciclicos de vasopresina de benzacepina
PT100514A (pt) 3-aminoquinuclidinas substituidas e composicoes farmaceuticas que qs contem
EA199800868A1 (ru) Конденсированные ариламидопиридины и пиримидины, содержащая их фармацевтическая композиция, способ лечения, промежуточные соединения и способ их получения
DE69532162D1 (de) Cannabinoid-rezeptor-antagonisten
EP0668863A1 (en) QUINUCLIDINE DERIVATIVE AS AN ANTAGONIST OF SUBSTANCE P.
DK0725782T3 (da) A1-adenosin-receptor-agonister og antiagonister
NO952398L (no) Pyrrolpyrimidiner som CRF antagonister
CO5011096A1 (es) Medicamentos que contienen antagonistas del receptor 5-ht3 para el tratamiento de la ibs
ATE293448T1 (de) Benzo(d)azepin-derivative als 5-ht6-rezeptor- antagonisten
MX9203320A (es) Composicion antialergica que contiene compuestos biciclicos switterionicos.
DE69413535D1 (de) 1-phenylalkanone als 5-ht4 rezeptor ligande
MX9300948A (es) Un antagonista novedoso del receptor 5ht3
ES556864A0 (es) Procedimiento para la obtencion de benzopiranos sustituidos.
PT684816E (pt) Composicoes antagonistas do receptor da 5-ht2 uteis no tratamento de doencas venosas
AU3422800A (en) Use of 5-ht3 receptor antagonists
ES2121984T3 (es) Uso de antagonistas de 5-ht4 para la fabricacion de un medicamento para el tratamiento de la incontinencia urinaria.
ES2166462T3 (es) Antagonistas del receptor de la endotelina.
MX9302985A (es) Composicion farmaceutica para el tratamiento y la profilaxis de la ansiedad.
AR004719A1 (es) Compuestos debisindolilmaleimidas con un punte n, n' y formulaciones farmaceuticas que los contienen, dichos compuestos son utiles comointermediarios para preparar otras bisindolilmaleimidas que poseen dicho puente n, n'